Michael Celano

Insider Reports History

Entity
Individual
Location
220 East First Street, Bethlehem, PA
Signature
/s/ Jennifer Johansson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Celano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ORASURE TECHNOLOGIES INC Director Common Stock 112K $915K $8.19 Aug 12, 2022 Direct
Larimar Therapeutics, Inc. Chief Financial Officer Common Stock 144K $537K $3.73 Jan 17, 2024 Direct
Larimar Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 188K Jan 17, 2024 Direct

Insider Reports Filed by Michael Celano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LRMR Larimar Therapeutics, Inc. Jan 17, 2024 2 $0 4 Jan 19, 2024 Chief Financial Officer
LRMR Larimar Therapeutics, Inc. May 17, 2023 1 $18.6K 4 May 18, 2023 Chief Financial Officer
LRMR Larimar Therapeutics, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Financial Officer
LRMR Larimar Therapeutics, Inc. Sep 16, 2022 1 $100K 4 Sep 19, 2022 Chief Financial Officer
OSUR ORASURE TECHNOLOGIES INC Aug 12, 2022 1 $53.9K 4 Aug 16, 2022 Director
OSUR ORASURE TECHNOLOGIES INC May 16, 2022 2 $112K 4 May 18, 2022 Director
LRMR Larimar Therapeutics, Inc. May 10, 2022 1 $0 4 May 12, 2022 Chief Financial Officer
LRMR Larimar Therapeutics, Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 Chief Financial Officer
OSUR ORASURE TECHNOLOGIES INC May 17, 2021 2 $111K 4 May 19, 2021 Director